| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0924-8579(03)00245-0 |
| P698 | PubMed publication ID | 14659650 |
| P50 | author | Helio S Sader | Q63144492 |
| Ronald N Jones | Q120908182 | ||
| P2093 | author name string | Mondell L Beach | |
| P2860 | cites work | Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients | Q43843930 |
| Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). | Q44054801 | ||
| Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam | Q44266822 | ||
| ICU-acquired nosocomial infection: impact of delay of adequate antibiotic treatment. | Q51686923 | ||
| Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. | Q54127739 | ||
| National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998 | Q56898619 | ||
| Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii | Q63197407 | ||
| Seasonal variation of Acinetobacter infections: 1987-1996. Nosocomial Infections Surveillance System | Q64131324 | ||
| Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents | Q24550655 | ||
| Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria | Q33756519 | ||
| Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines | Q33970910 | ||
| Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. | Q34128899 | ||
| Monotherapy versus combination therapy for bacterial infections. | Q34130045 | ||
| Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. | Q34177418 | ||
| Surveillance of antibiotic resistance in European ICUs. | Q34299810 | ||
| Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. | Q35005719 | ||
| Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites | Q39590902 | ||
| Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199 | Q43587149 | ||
| Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. | Q43587157 | ||
| P433 | issue | 6 | |
| P921 | main subject | Gram-negative bacteria | Q632006 |
| P304 | page(s) | 551-556 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
| P1476 | title | Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). | |
| P478 | volume | 22 |
| Q40052282 | A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against Stenotrophomonas maltophilia |
| Q35148622 | Antibiogram of Stenotrophomonas maltophilia Isolated From Nkonkobe Municipality, Eastern Cape Province, South Africa |
| Q35698764 | Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon |
| Q35767386 | Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital |
| Q46815367 | Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). |
| Q36749895 | Antimicrobial therapy for Stenotrophomonas maltophilia infections |
| Q42846946 | Aqueous and Vitreous Penetration of Linezolid and Levofloxacin After Oral Administration |
| Q24813204 | Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit |
| Q37838126 | Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter? |
| Q37681071 | Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series |
| Q50163036 | Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia |
| Q40925635 | Clinical ineffectiveness of latamoxef for Stenotrophomonas maltophilia infection |
| Q24672751 | Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia |
| Q53127696 | In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). |
| Q47145196 | Intraabdominal abscess caused by Stenotrophomonas maltophilia: A case report |
| Q79190581 | Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units? |
| Q37101552 | Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection |
| Q38101380 | Levofloxacin for the treatment of pyelonephritis |
| Q38188881 | Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. |
| Q37382976 | Management of meningitis due to antibiotic-resistant Acinetobacter species |
| Q37139730 | Meropenem: a review of its use in the treatment of serious bacterial infections. |
| Q42317668 | Multidrug-resistant Acinetobacter meningitis treated by intrathecal colistin |
| Q37956403 | Pharmacological considerations for the proper clinical use of aminoglycosides |
| Q36839703 | Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination |
| Q40412684 | Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections. |
| Q90341632 | Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival |
| Q41712194 | Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience |
| Q37763019 | Stenotrophomonas maltophilia: Significant contemporary hospital pathogen - review |
| Q37866819 | Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. |
| Q92127808 | The dishwasher rubber seal acts as a reservoir of bacteria in the home environment |
| Q44596044 | Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections |
| Q26782924 | Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options |
| Q44789517 | Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital |
Search more.